Daré Bioscience, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €8.44K -99.7% -€3.50M -86.6% -41,435.0% -400 pp €5.15M -115.6% 60,990.3% +620 pp
    €2.42M -71.9% -€26.02M -2.5% -1,074.1% -7.6 pp -€32.97M +112.1% -1,361.4% -12 pp
    €8.63M +∞% -€26.70M -19.3% -309.5% -3.1 pp -€15.55M -37.3% -180.3% -1.8 pp
    €0.00 +NaN% -€33.06M +39.9% N/A -€24.80M +14.0% N/A
    €0.00 +NaN% -€23.64M +92.1% N/A -€21.75M +89.4% N/A
    €0.00 +NaN% -€12.30M -14.8% N/A -€11.49M +29.8% N/A
    €0.00 +NaN% -€14.44M +45.5% N/A -€8.85M +303.8% N/A
    €0.00 -100.0% -€9.92M -70.7% N/A -€2.19M -92.3% N/A
    €660.74K +∞% -€33.90M -0.7% -5,131.2% -51 pp -€28.47M +4.3% -4,308.2% -43 pp
    €0.00 -100.0% -€34.15M +69.6% N/A -€27.29M +68.0% N/A
    €69.01K +1,233.3% -€20.13M +36.2% -29,177.5% +2.6K pp -€16.25M +13.4% -23,545.0% +2.5K pp
    €5.18K -99.0% -€14.79M -22.4% -285,716.7% -2.8K pp -€14.33M -20.3% -276,783.3% -2.7K pp
    €539.12K +104.9% -€19.06M +13.0% -3,536.2% +29 pp -€17.96M +25.0% -3,332.0% +21 pp
    €263.09K -€16.87M -6,414.1% -€14.37M -5,462.6%

    Notifications